These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 174515)

  • 21. [The importance of estrogen receptors in the pharmacotherapy of mammary carcinoma (author's transl)].
    Bolt HM
    MMW Munch Med Wochenschr; 1975 Feb; 117(9):333-6. PubMed ID: 164623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone therapy of breast cancer].
    Maass H
    Med Welt; 1976 May; 27(21):1047-51. PubMed ID: 180375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results and merit of estrogen receptor data derived from metastatic tumors of the breast.
    Jochimsen PR; Ness SJ; Sherman BM
    Surg Gynecol Obstet; 1978 Dec; 147(6):842-4. PubMed ID: 715657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
    Kurbel S
    Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estrogen receptors in breast cancers and endocrine therapy].
    Maass H; Trams G; Nowakowski H
    Strahlentherapie; 1974 Apr; 147(4):381-7. PubMed ID: 4369557
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic value of estrogen receptor to endocrine ablation in cancer of the breast.
    Leung BS; Krippaehne WW; Fletcher WS
    Surg Gynecol Obstet; 1974 Oct; 139(4):525-8. PubMed ID: 4138654
    [No Abstract]   [Full Text] [Related]  

  • 27. [The clinical significance of hormone receptors in the treatment of breast cancer].
    Trams G
    Fortschr Med; 1979 Apr; 97(14):641-4. PubMed ID: 437632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
    Osborne CK; McGuire WL
    Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New approaches to reverse resistance to hormonal therapy in human breast cancer.
    Weinberg OK; Marquez-Garban DC; Pietras RJ
    Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of estrogen receptors in human breast cancer.
    Olsnes S; Pihl A
    Biomedicine; 1974 Nov; 20(6):377-83. PubMed ID: 4376029
    [No Abstract]   [Full Text] [Related]  

  • 34. Endocrine therapy and other targeted therapies for metastatic breast cancer.
    Hussain SA; Palmer DH; Moon S; Rea DW
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer of the breast. Endocrine and hormonal therapy.
    Kardinal CG; Donegan WL
    Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of hormone receptors in the therapy of breast cancer].
    Obrist R; Obrecht JP
    Schweiz Med Wochenschr; 1983 May; 113(20):749-53. PubMed ID: 6879128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
    Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
    Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
    Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endocrine therapy of recurrent breast cancer].
    Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.